Intervju med Dr James Garner, VD Kazia Therapeutics
-
Regulatoriska pressmedddelanden 30 november, 2022Vivesto meddelar att Christer Nordstedt kvarstår som tillförordnad VD under en övergångsperiod
-
Regulatoriska pressmedddelanden 21 november, 2022Vivesto utser Erik Kinnman till verkställande direktör
-
Regulatoriska pressmedddelanden 21 november, 2022Valberedning utsedd inför Vivestos årsstämma 2023
Vivesto publicerade sin delårsrapport för tredje kvartalet 2022 den 17 november 2022 kl. 8.00.
Oasmia förvärvar globala rättigheter för utveckling och kommersialisering av Cantrixil – ett kliniskt program inom äggstockscancer
We published our Q2 results today, which show continued cost control, with a reduction in operating expenses.
#oncology #biotech
Interim report for the period January 1, 2022 – June 30, 2022 - Vivesto
SIGNIFICANT EVENTS DURING THE SECOND QUARTER In April Daniel Tesfa was appointed Chief Medical Officer. In April Vivesto signed an agreement with...
www.vivesto.com
For #investors and #media:
Today Inceptua launched Apealea® in Germany. This is great news for patients but also for Vivesto’s business as we are eligible for royalties on any sales.
#oncology #biotech
Vivesto notes the launch of Apealea® in Germany by Inceptua - Vivesto
Solna, Sweden, 15 August 2022 – Vivesto AB, an oncology-focused specialty pharmaceutical company, is pleased to note...
www.vivesto.com
This #MensHealthWeek have a look at this campaign by @menshealthforum all about how to carry out a MAN-MOT. Your car gets one regularly so why not all men? This article shows how to do your own and help early diagnosis of Prostate cancer.
Read more here:
DIY Man MOT
Your car gets one regularly but what about you? No, not a parking ticket, an MOT. Giving your body a once-over...
bit.ly